30/05/2017

MSD To Create More Than 300 New Jobs In Carlow And Cork

Global biopharmaceutical company MSD has revealed plans is to create 330 new jobs in Carlow and Cork.

Making the announcement today, 30 May, the organisation added it will invest €280 million over the next three years at the two sites due to increased demand for its medicines and vaccines produced in Ireland.

MSD's facility in Brinny, Co. Cork, is an integrated site for the development, testing and manufacturing of biologics, specialising in the fermentation, purification and sterile filling of biotech products. Over 200 new roles will be created to meet demand for work on some of the company's important treatments – medicines for lung cancer, melanoma, hepatitis C and rheumatoid arthritis.

Elsewhere, the company's manufacturing site in Carlow will see 120 new roles created at the site. Carlow also is an important link in MSD's network of sites producing its new immuno-oncology treatment for the global market.

Overall, the new roles to be created include technical, engineering, biochemistry, biology, quality and operations positions.

Minster for Jobs, Enterprise & Innovation, Mary Mitchell O'Connor, TD welcomed the announcement while addressing over 1,200 senior MSD business leaders at the company's annual Europe, Middle East, Africa & Canada Congress in Dublin.

Addressing the Congress, the Minister said she: "Warmly welcomed the new investment and additional jobs announced by the company for their facilities in Carlow and Co. Cork. MSD has been at the cutting edge of bio pharmaceutical innovation over recent years and their Irish operations are at the heart of many of the company's exciting new products.

"It is particularly gratifying that this expansion and additional job creation will take place in two regional locations, thereby strengthening the Government's efforts to ensure balanced industrial development around the country."

Sanat Chattopadhyay, MSD Executive Vice President and President of MSD's Manufacturing Division, said: "Today's announcement is a reflection of MSD Ireland's positive standing in our global network, a vote of confidence in our people and their work, and a sign of MSD's future commitment to Ireland.

"The expansion of our presence in Ireland is a testament to the talent of our Irish employees. In recent years our Irish businesses have played an increasingly important role in the production of some of MSD's most important breakthrough medicines for the global market."

(LM/CD)

Related Northern Ireland Recruitment News Stories
Click here for the latest headlines.

04 November 2008
Jobs Boost for Cork And Carlow
There's to be a jobs' bonanza in counties Carlow and Cork with news of hundreds of new jobs. Some are to be created by pharmaceutical company Merck Sharp & Dohme which has announced it will boost local employment with 170 jobs at a new vaccine facility in Carlow.
28 June 2001
NEW SOFTWARE COMPANY TO PROVIDE 165 NEW JOBS IN BELFAST
AN £11.3 million investment by Meridio Ltd, a new international technology company, will provide 165 new jobs, 45 of which are already in place, in Belfast.
10 February 2015
Purepipe To Create Six New Jobs
Belfast-based Purepipe is investing £250,000 and creating six new jobs as part of plans to boost sales in Great Britain and the Republic of Ireland. Invest Northern Ireland has offered the company £45,000 towards its expansion which involves investing in new state-of-the-art specialised pipe manufacturing equipment needed to target new business.
27 March 2013
Tesco To Recruit 200 New Staff
Tesco has announced that it is recruiting over 200 new staff for its new store which will open in Newry on 6 June 2013. The announcement was welcomed today by Employment and Learning Minister Dr Stephen Farry as recruitment opened for the new store. The Minister described the jobs boost as good news for jobseekers in the Newry area.
01 August 2017
Bausch + Lomb Create 125 New Jobs
Bausch + Lomb has announced the opening of a new €85 million extension at the their Waterford facility, with the creation of 125 new jobs. Valeant Pharmaceuticals International, the parent company of Bausch + Lomb, has invested more than €200 million in the Waterford facility's operations, infrastructure and manufacturing line growth.